García-Rodríguez AM, Sánchez-González CM, Osorio-Caballero M, Díaz NF, Flores-Herrera H

Language: Spanish
References: 23
Page: 174-185
PDF size: 619.61 Kb.

ABSTRACT

Objective: To determine the expression profile of miRNA-21, -106, -126 and -146 and to quantify the secretion of IL-1β in the serum of healthy pregnant patients at term with and without active labor and in patients with clinical evidences of chorioamnionitis.
Materials and Methods: Analytical, longitudinal, and prolective study carried out in patients admitted for control, obstetric, and pregnancy resolution into the National Institute of Perinatology in Mexico City between February 2015 and August 2016. Study variables: healthy pregnant patients at term with and without active labor and patients with clinical evidence of chorioamnionitis, maternal and gestational age. Five milliliters of peripheral blood were taken from each patient, which was centrifuged, and the serum recovered. RNA was obtained from 500 µL of serum to which the same volume of TRIzol reagent was added. The cDNA was synthesized with 3 ng of RNA by the reverse transcription assay. The expression of the microRNAs was performed by polymerase chain reaction (PCR) with specific primers. The results are presented as mean ± standard deviation and statistical analysis was performed using the Mann-Whitney test with a significant difference of p<0.05.
Results: In healthy pregnant patients with active labor, it was observed that the expression profile of miR-126 increased 1.23-fold (p≤0.001); while the miR-21 and miR-146 decreased 2.1- (pp≤0.001) and 0.73-fold (p≤0.001) respectively and the concentration of IL-1β increased 1.8-fold (p = 0.014) with respect to the healthy patients without labor. The expression profile of these miRNAs and IL-1β change in patients with clinical evidence of chorioamnionitis. The miR-126 and miR-146 increased 1.31- (p≤0.001) and 1.1-fold (p = 0.05); while miR-21 decreased 1.4-fold (p≤0.05) and the concentration of IL-1β increased 2.88-fold (p = 0.002) with respect to patients without active labor. The miR-106 did not show significant differences between the three study groups.
Conclusions: These results suggest that miRNA-21, -126 and -146 could be considered as molecular markers in the development of chorioamnionitis; however, more tests should be carried out to corroborate this pattern and evaluate its efficiency.

REFERENCES

1. Hecht JL, Onderdonk A, Delaney M, Allred EN, Kliman HJ, Zambrano E, et al. Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues. Pediatr Dev Pathol. 2008; 11(1): 15-22.

2. Prince AL, Ma J, Kannan PS, Alvarez M, Gisslen T, Harris RA, et al. The placental membrane microbiome is altered among subjects with spontaneous preterm birth with and without chorioamnionitis. Am J Obstet Gynecol. 2016; 214(5): 627 e1-627 e16.

3. Rouse DJ, Landon M, Leveno KJ, Leindecker S, Varner MW, Caritis SN, et al. The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol. 2004; 191(1): 211-6.

4. Dars S, Malik S, Samreen I, Kazi RA. Maternal morbidity and perinatal outcome in preterm premature rupture of membranes before 37 weeks gestation. Pak J Mes Sci. 2014; 30(3): 626-9.

5. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PloS one. 2008; 3(8): e 3056.

6. Freitas AC, Chaban B, Bocking A, Rocco M, Yang S, Hill JE et al. The vaginal microbiome of pregnant women is less rich and diverse, with lower prevalence of Mollicutes, compared to non-pregnant women. Sci Rep. 2017; 7(1): 9212.

7. Parry S, Strauss JF 3rd. Premature rupture of the fetal membranes. N Engl J Med. 1998; 338(10): 663-70.

8. Denson LA, McDonald SA, Das A, Schendel DE, Skogstrand K, Hougaard DM et al. Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol. 2017; 34(3): 240-247.

9. Splichal I, Trebichavsky I. Cytokines and other important inflammatory mediators in gestation and bacterial intraamniotic infections. Folia Microbiol. 2001; 46(4): 345-51.

10. Sato BL, Collier ES, Vermudez SA, Junker AD, Kendal-Wright CE. Human amnion mesenchymal cells are pro-inflammatory when activated by the Toll-like receptor 2/6 ligand, macrophage- activating lipoprotein-2. Placenta. 2016; 44: 69-79.

11. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009; 9(6): 703-711.

12. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010; 10(2): 111-22.

13. Oglesby IK, McElvaney NG, Greene CM. MicroRNAs in inflammatory lung disease-- master regulators or target practice? Respir Res. 2010; 11: 148.

14. Behnia F, Taylor BD, Woodson M, Kacerovsky M, Hawkins H, Fortunato SJ et al. Chorioamniotic membrane senescence: a signal for parturition? Am J Obstet Gynecol. 2015; 213(3): 359 e1-16.

15. Montenegro D, Romero R, Pineles BL, Tarca L, Kim YM, Draghici S, Kusanovic JP, et al. Differential expression of microRNAs with progression of gestational and inflammation in the human choriamniotic membranes. Am J Obstet Gynecol 2007;197(3):289

16. García-Gudiño I, Yllescas-Medrano E, Maida-Claros R, Soriano.Becerril D, Díaz NF, García-López G, et al. Microbiological comparison of blood culture and amplification of 16S rDNA methods in combination with DGGE for detection of neonatal sepsis in blood samples. Eur J Pediatr 2018; 177(1):85-93.

17. Osorio-Caballero M, Perdigón-Palacio C, García-López G, Flores-Herrera O, Olvera-Sanchez S, Morales-Méndez I, et al. Escherichia coli-induced temporal and differential secretion ofheat-shock protein 70 and interleukin-1β by human fetal membranes in a two-compartament culture system. Placenta 2015;36(3):262-269.

18. Bounds KR, Chiasson VL, Pan LJ, Gupta S, Chatterjee P. MicroRNAs: New Players in the Pathobiology of Preeclampsia. Front Cardiovasc Med. 2017; 4: 60.

19. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K, Williams MA. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2011; 204(2): 178 e12-21.

20. Hromadnikova I, Kotlabova K, Ivankova K, Krofta L. Expression profile of C19MC microRNAs in placental tissue of patients with preterm prelabor rupture of membranes and spontaneous preterm birth. Mol Med Rep. 2017; 16(4): 3849-3862.

21. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner- Svensson HM, Lindsay MA. Rapid changes in microRNA- 146a expression negatively regulate the IL-1beta- induced inflammatory response in human lung alveolar epithelial cells. J Immunol. 2008; 180(8): 5689-98.

22. Huleihel M, Golan H, Hallak M. Intrauterine infection/inflammation during pregnancy and offspring brain damages: possible mechanisms involved. Reprod Biol Endocrinol. 2004; 2: 17-24.

23. Miyazaki K, Furuhashi M, Matsuo K, Minami K, Yoshida K, Kuno N et al. Impact of subclinical chorioamnionitis on maternal and neonatal outcomes. Acta Obstet Gynecol Scand. 2007; 86(2): 191-7.